Pooneh Salari
Assistant Professor, Clinical Pharmacist at Medical Ethics and History of Medicine Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
Selected publications:
  • 1. Salari P, Rezaei A, Larijani B, Abdollahi M. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Medical Science Monitor 2008; 14(3): RA37-RA44.
  • 2. Salari P, Larijani B, Abdollahi M. Association of hyperhomocysteinemia with osteoporosis: A systematic review. Therapy 2008; 5(2): 215- 222.
  • 3. Salari P, Abdollahi M. Current opinion in the management of irritable and inflammatory bowel diseases: role of ATP. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2009; 3(1): 69-75.
  • 4. Salari P, Abdollahi M. Controversial effects of non-steroidal anti-inflammatory drugs on bone: a review. Inflammation & Allergy- Drug Targets 2009; 8(3): 169-75.
  • 5. Salari P, Asalforoush M, Ameri F, Larijani B, Abdollahi M. The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. Age 2009; 32(2): 179-86.
  • 6. Salari Sharif P, Abdollahi M. A systematic review on the relationship between β-blockers and bone health. Int J Pharmacol 2010; 6(5): 577-83.
  • 7. Salari Sharif P, Abdollahi M. A systematic review on the relation between use of statins and osteoporosis. Int J Pharmacol 2011; 7(2): 180-188.
  • 8. Salari Sharif P, Abdollahi M. The role of platelets in bone remodelling. Inflamm Allergy Drug Targets 2010; 9: 393-9.
  • 9. Salari P, Javadi M, Asghari F. Pharmacy ethics: evaluating pharmacists ethical attitude. J Med Ethics Hist Med 2011; 4: 5.
  • 10. Salari P, Abdollahi M, Larijani B. Current new and future treatments of osteoporosis. Rheumatol Int 2011; 31: 289-300.
  • 11. Salari Sharif P, Abdollahi M. Phosphodiesterase 4 inhibitors in inflammatory bowel disease: a comprehensive review. Curr Pharm Design 2010; 16: 3661-7.
  • 12. Salari P, Abdollahi. A systematic review on the relationship between use of statins and osteoporosis. Int J Pharmacol 2011; 7(2): 180-8.
  • 13. Salari P, Nikfar S, Abdollahi M. Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: a meta-analysis. Age 2011; 33: 421-31.
  • 14. Javadi M, Asghari F, Salari P. Assessment of professionalism in Iranian pharmacists. J Med Ethics Hist Med 2011; 4: 6.
  • 15. Salari P, Abdollahi M. A comprehensive review of the shared roles of inflammatory cytokines in osteoporosis and cardiovascular diseases as two common old people problem; action toward development of new drugs. Int J Pharmacol 2011; 7(5): 552-67.
  • 16. Salari P. Successes in understanding pathophysiology of osteoporosis. Int J Pharmacol 2011; 7(6): 677-78.
  • 17. Salari P. New horizons in management of inflammatory bowel disease. Int J Pharmacol 2011; 7(6): 679-81.
  • 18. Salari P, Nikfar S, Abdollahi M. A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm Allerg Drug Target 2012; (under publication)
  • 19. Salari P, Abdollahi M. Systematic review of modulators of benzodiazepine receptors in irritable bowel syndrome: is there hope? World J Gastroenterol 2011; 17(38): 4251-7.
  • 20. Salari P, Nikfar S, Abdollahi M. No superiority of exenatide over insulin in diabetic patients in terms of weight reduction or incidence of adverse effects: a meta-analysis. Int J Pharmacol 2011; 7(7): 749-56.
  • 21. Nikfar S, Abdollahi M, Salari P. The efficacy and tolerability of exenatide: a systematic review and meta-analysis of randomized clinical trials. J Pharm Pharmaceut Sci 2012; 15(1): 1-30.
  • 22. Salari P, Bagheri A. Celecoxib: ethical evaluation of a setting of clinical trials. J Med Ethics Hist Med 2011; 4(Suppl): 26-32 (in Persian)
  • 23. Salari P, Abdollahi N. Behind the pathogenesis of osteoporosis and cardiovascular diseases. Arch Med Sci 2011; 7(4): 568.
  • 24. Salari P, Abdollahi M. Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back. J Pharm Pharmaceut Sci 2012; 15(2): 305-317.
  • 25. Mobasher M, Salari P, Larijani B. Key ethical issues in pediatric research: Islamic perspective, Iranian experience. Iranian J Pediatr 2012; 22(4): 435-444.
  • 26. Parsapoor A, Salari P, Larijani B. Implementation of patients right charter: a report from Ministry of Health and Medical Education, Iran. Iranian J Public Health 2013; 42(Suppl 1): 9-12.
  • 27. Barylski M, Nikfar S, Mikhailidis DP, Toth PP, Salari P, et al. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy-a meta-analysis of 11 randomized controlled trials involving 21,295 participants. Pharmacological Research 2013; 72: 35-44
  • 28. Nikolic D, Nikfar S, Salari P, et al. Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. Curr Med Res Opin 2013; 29(5): 435-51.
  • 29. Salari P, Abdollahi M. Phosphodiesterase inhibitors in inflammatory bowel disease. Expert Opin Investig Drugs 2012; 21(3): 261-4.
  • 30. Nikolic D, Banach M, Nikfar S, Salari P. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? Int J Cardiol 2013; 168: 5437-47.
  • 31. Salari P, Namazi HR, Abdollahi M, et al. Code of ethics for the national pharmaceutical system: codifying and compilation. J Res Med Sci 2013; 18(5): 442-8.


Research Projects:
1. “The beneficial effects of omega-3 fatty acids on bone health and osteoporosis” in Endocrinology and Metabolism Research Center of Tehran University of Medical Sciences.[2 dissertations]
2. “A survey into ethical attitude of pharmacists” in Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences
3. “ A survey into professionalism in pharmacy practice” in Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences
4. Compiling complementary document of pharmacy ethics of Iran in Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences

Research Projects in Progress:
1. “Evaluation the beneficial effects of folic acid on bone metabolism and the relationship between serum levels of vitamin B12 and bone biomarkers in postmenopausal osteoporotic women”. in Endocrinology and Metabolism Research Center of Tehran University of Medical Sciences
2. “Surveying the effect of β-blocker usage on fracture risk.” In Endocrinology and Metabolism Research Center of Tehran University of Medical Sciences. [dissertation]
3. “ Evaluating Ca score and its relationship with bone density and bone biomarkers” in Endocrinology and Metabolism Research Center of Tehran University of Medical Sciences
 
FOUNDING PARTNERS:






Lipid and Blood Pressure
Meta-analysis Collaboration Group
Zeromskiego 113
90-549 Lodz, Poland
Phone/Fax: +48 42 639 37 71
Email: maciej.banach@umed.lodz.pl
© 2018 LBPMC. All rights reserved.